This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.
Show more...
CEO
Employees
219
Country
US
ISIN
US54948U1051
Listings
0 Comments
Share your thoughts
FAQ
What is Lucira Health stock price today?▼
The current price of LHDX is $0.45 USD — it has decreased by -19.23% in the past 24 hours. Watch Lucira Health stock price performance more closely on the chart.
What is Lucira Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lucira Health stocks are traded under the ticker LHDX.
What is Lucira Health market cap?▼
Today Lucira Health has the market capitalization of 18.14M
What is Lucira Health revenue for the last year?▼
Lucira Health revenue for the last year amounts to 93.06M USD.
What is Lucira Health net income for the last year?▼
LHDX net income for the last year is -64.83M USD.
How many employees does Lucira Health have?▼
As of April 03, 2026, the company has 219 employees.
In which sector is Lucira Health located?▼
Lucira Health operates in the Manufacturing sector.
When did Lucira Health complete a stock split?▼
Lucira Health has not had any recent stock splits.